期刊文献+

EphA2蛋白在宫颈癌组织中的表达及意义

Expression of EphA2 in cervical cancer tissues and its significance
下载PDF
导出
摘要 目的 探讨EphA2蛋白在宫颈癌组织中的表达及其意义.方法 收集宫颈鳞状细胞癌石蜡标本80例作为观察组,另收集宫颈上皮内瘤变石蜡标本20例及因良性病变行子宫切除术患者的正常宫颈组织10例作为对照组.采用多克隆抗体免疫组化SP染色法检测EphA2蛋白在宫颈癌组织中的表达水平.结果 EphA2蛋白在正常宫颈、宫颈上皮内瘤变、宫颈癌Ⅰb1和Ⅰb2期组织中表达的总体阳性率分别为20.0%、50.0%、80.0%、95.0%,总体阳性率比较差异有统计学意义(χ^2=31.476,P〈0.05).观察组1(宫颈癌Ⅰb1期)和观察组2(宫颈癌Ⅰb2期)组织中EphA2蛋白表达的阳性率分别为80.0%、95.0%,经比较差异有统计学意义(χ^2=4.114,P〈0.05).宫颈病变的进展与EphA2蛋白的表达强度之间呈线性相关(r=0.990,P=0.010).高、中和低分化的宫颈癌组织中EphA2蛋白表达的阳性率分别为68.8%、90.6%和100.0%,经比较差异有统计学意义(χ^2=7.173,P〈0.05);组织分化程度与EphA2蛋白阳性表达强度呈线性相关(r=0.977,P=0.016).在有淋巴结转移和无淋巴结转移的宫颈癌组织中,EphA2蛋白的表达阳性率分别为100.0%和82.5%,经比较差异有统计学意义(χ^2=4.612,P〈0.05).结论 EphA2蛋白的高表达与肿瘤大小、组织学分级、淋巴结转移等预后因素密切相关,其可望作为预测宫颈癌恶性程度及预后的分子指标. Objective To study expression of EphA2 in cervical cancer tissues and its significance. Methods The paraffin specimens of 80 patients with cervical squamous cancer (as study group) and 20 patients with CIN( as observation group) ,and normal cervical tissues of 10 patients who received hysterectomy due to benign cervical lesions (as the control group) were collected. The polyclonal antibody SP immunohistochemistry staining method was used to detect expression level of EphA2 in cervical cancer tissues. Results The positive rate of EphA2 in I b2 and I b1 cervical cancer tissues were significantly higher than that in CIN and normal cervical tissues (95.0%, 80.0% , 50.0%, 20.0% respectively; χ^2 =31. 476,P 〈 0.05 ). The positive rate of EphA2 in stage I b2 cervical cancer tissues was significantly χ^2 higher than that in stage I bl cervical cancer tissues (95.0% vs 80.0% ; = 4. 114, P 〈 0.05 ). There was a significant liner relation between progression of cervical cancer and expression intensity of EphA2 ( r = 0. 990, P = 0. 010 ). The positive rate of EphA2 in pooly differentiated cervical cancer tissues and moderatedly differentiated cervical cancer tissues was significantly higher than that in highly differentiated cervical tissues ( 100.0%, 90.6% , 68.8% respectively ; χ^2 = 7. 242, P 〈 0.05 ) and there was a significant liner relation between differentiation degree of cervical cancer and expression intensity of EphA2 ( r = 0.977,P = 0.016). The positive rate of EphA2 in cervical cancer tissues with lymphatic metastasis was significantly higher than that in cervical cancer tissues without lymphatic metastasis ( 100.0% vs 82.5% ;X^2 = 4. 612, P 〈 0.05) Conclusion There is a close relationships between expression of EphA2 and prognostic factors such as size of tumor, hystological grading and lymphatic metastasis. So EphA2 can be used as a molecular biological index to evaluate degree of malignacy and prognosis of cervical cancer.
出处 《中国妇幼健康研究》 2010年第3期327-329,共3页 Chinese Journal of Woman and Child Health Research
关键词 宫颈癌 EphA2蛋白 免疫组织化学 宫颈上皮内瘤变 cervical cancer EphA2 immunohistochemistry cervical intraepithelial neoplasia (CIN)
  • 相关文献

参考文献10

  • 1Walker D J,Hess A R,Hendrix M J,et al.Diferential regulation of EphA2 in normal and malignant cells[J].Am J Pathol,2003,162(4):1037-1042.
  • 2Katuoka H,Igarashi H,Kanamori M,et al.Correlation of EphA2 overexpression with high microvessel count in human primary coloreetal cancer[J].Cancer Sci,2004,95(2):136-141.
  • 3Kinch M S,Carlos K K.Overexpression and functi6nal alterations of the EphA2 tyrosine kinase in cancer[J].Clin Exp Metastasis,2003,20(1):59-68.
  • 4WU Dan,SUO Zhen-he,Kristensen G B,et al.Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma[J].Gynecol Oncol,2004,94(2):312-319.
  • 5范波,姚珍薇.EphA2在宫颈癌中表达的临床意义及与患者预后的关系[J].华西医学,2008,23(1):78-79. 被引量:2
  • 6王平,路平.Cox回归探讨宫颈癌预后影响因素[J].国外医学(妇幼保健分册),2002,13(5):273-275. 被引量:17
  • 7Miyazski T,Kate H,Fukuchi M,et al.EphA2 overexpression correlates with poor prognosis in esophageal squamous ee1l carcinoma[J].Int J Cancer,2003,103(5):657-663.
  • 8Kinch M S,More M B,Harpole DH Jr.Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival[J].Clin Cancer Res,2003,9(2):613-618.
  • 9Brantley D M,Chen N,Thompson E J,et al.Soluble EphA receptors inhibit tumor angiogenesis and progression in vivo[J].Oncogene,2002,21(46):7011-7026.
  • 10Dobrzanski P,Hunter K,Jones B S,et al.Antianglogenie and anfitunoreficacy of EphA2 receptor antagonist[J].Cancer Ros,2004,64(3):910-919.

二级参考文献14

  • 1Davis S,Gale NW,Aldrich TH,et al.Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity[J].Science,1994,266(5186):816-819.
  • 2Kataoka H,Igarashi H,Kanamori M,et al.Correlation of EPHA2 overexpression with high microvessel count in human primary coloreetal cancer[J].Cancer Sci,2004,95(2):136-141.
  • 3Walker-Daniels J,Hess AR,Hendrix MJ,et al.Differential regulation of EphA2 in normal and malignant cells[J].Am J Pathol,2003,162(4):1037-1042.
  • 4Iantek ND,Walker-Daniels J,Stewart J,et al.MCF-10A-NeoST:a new cell system for studing cell-ECM and cell-cell interactions in breast cancer[J].Clin Cancer Res,2001,7(11):3640-3648.
  • 5Kinch MS,Carles-Kinch K.Overexpression and functional alterations of the EphA2 tyrosine kinase in canaer[J].Clin Exp Metastasis,2003,20(1).
  • 6Wu D,Suo Z.Kristensen GB,et a1.Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma10[J].Gyneeol Oncol,2004,94(2):312-319.
  • 7Rutledge FN, Mitchell MF, Munsell M, et al. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis[J]. Gynecol Oncol,1992,44:123-130.
  • 8Carolyn M, Matthews, Thomas W, et al. Stage I cervical adenocarcinoma:prognostic evaluation of surgically treated patients[J]. Gynecologic Oncology, 1993,49:19-23.
  • 9Fuller AF, Elliott N, Kosloff C, et al. Determinants of increased risk for recurrence in patient undergoing radical hysterec-tomy for stage IB and IIA carcinoma of the cervix[J]. Gynecol Oncol,1989,33:34-39.
  • 10Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix[J]? Cancer,1995,76:1948-1955.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部